Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Recruitment Status: Terminated"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (826)
1
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer : A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
LYT-100 in Patients With BCRL : A Phase 2a Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of Deupirfenidone (LYT-100) in Patients With Breast Cancer-Related Upper Limb Secondary Lymphoedema
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors : A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTITUMOR ACTIVITY OF PF-07260437 IN ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer : A Muti-center, Open-label, Randomized, Phase III Study of Camrelizumab Plus Treatment of Physician Choice Versus Treatment of Physician Choice for Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Systemic Chemotherapy Regimens for Advanced/Metastatic Setting
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer : A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-Tumor Activity of AC682 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer : Randomized and Prospective Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant : An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer : A Phase Ib/III Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors : A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC : A Non-randomized, Non-comparative, Open-label, Window Trial of Entinostat Given With or Without Exemestane in Patients With Newly Diagnosed, Stage I-IIIC, Hormone Receptor - Positive (HR+) or Triple Negative Breast Cancer (TNBC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[83]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Recruitment Status: Terminated
Medienart
826
Aufsätze
826
E-Artikel
826
E-Ressourcen
Zeitschriftentitel
826
ClinicalTrials.gov
Thema
826
610
Breast Neoplasms
Recruitment Status: Terminated
730
Study Type: Interventional
329
Phase: Phase 2
258
Medical Condition: Breast Cancer
118
Phase: Phase 1
93
Study Type: Observational
59
Phase: Phase 3
58
Triple Negative Breast Neoplasms
57
Medical Condition: Metastatic Breast Cancer
45
Phase: Phase 1/Phase 2
44
Carcinoma
38
Neoplasms
35
Medical Condition: Breast Neoplasms
18
Lung Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Neoplasm Metastasis
15
Phase: Phase 1, Phase 2
14
Ovarian Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
349
2020-
456
2010-2019
21
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
826
Englisch
Haven't found what you're looking for?
Wird geladen...